Andrew Berens Score: 49
Analyst at
Leerink Partners,
H.C. Wainwright
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+37.3%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
63%
12 W / 7 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
92%
11 W / 1 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
25%
3 W / 9 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
17%
2 W / 10 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
82%
9 W / 2 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
69%
11 W / 5 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
33%
1 W / 2 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 03, 2026 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$165.00
Est. +81%
|
$91.35 | $123.80 |
Pending
|
$123.73
+35.4%
|
| Jun 03, 2026 |
Zymeworks BC Inc
ZYME
|
BUY |
$46.00
Est. +91%
|
$24.11 | $27.14 |
Pending
|
$26.31
+9.1%
|
| Jun 02, 2026 |
Celcuity Inc
CELC
|
BUY |
$155.00
Est. +66%
|
$93.37 | $108.32 |
Pending
|
$107.95
+15.6%
|
| May 15, 2026 |
Immunome Inc
IMNM
|
BUY |
$33.00
Est. +50%
|
$22.02 | $23.67 |
Pending
|
$23.61
+7.2%
|
| Dec 17, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$873.00
Est. +17%
|
$746.36 | $821.11 |
Pending
|
$654.27
-12.3%
|
| Nov 17, 2025 |
Zymeworks BC Inc
ZYME
|
BUY |
$37.00
Est. +55%
|
$23.90 | $29.75 |
Pending
|
$26.31
+10.1%
|
| Nov 11, 2025 |
Zentalis Pharmaceuticals Inc
ZNTL
|
BUY |
$2.00
Est. +52%
|
$1.32 | $6.95 |
Target Met
|
$4.46
+237.9%
|
| Apr 02, 2025 |
Compass Therapeutics Inc
CMPX
|
BUY |
$6.00
Est. +255%
|
$1.69 | $6.77 |
Target Met
|
$2.27
+34.3%
|
| Jan 17, 2025 |
Lilly(Eli) & Co
LLY
|
BUY |
$950.00
Est. +28%
|
$740.15 | $1,133.95 |
Target Met
|
$1,210.50
+63.5%
|
| Nov 21, 2024 |
Zymeworks BC Inc
ZYME
|
BUY |
$26.00
Est. +90%
|
$13.68 | $26.19 |
Bullseye Hit (±1%)
|
$26.31
+92.3%
|
| Nov 05, 2024 |
Ideaya Biosciences Inc
IDYA
|
SELL |
$27.00
Est. +9%
|
$29.58 | $13.45 (Low) |
Target Met
|
$37.65
-27.3%
|
| Nov 01, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$880.00
Est. +4%
|
$843.60 | $862.00 |
Precision Hit (±3%)
|
$654.27
-22.4%
|
| Oct 21, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$96.00
Est. +11%
|
$86.72 | $124.61 |
Target Met
|
$131.27
+51.4%
|
| Oct 14, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$990.00
Est. +6%
|
$932.06 | $937.00 |
Miss
|
$1,210.50
+29.9%
|
| Sep 27, 2024 |
Agios Pharmaceuticals Inc
AGIO
|
BUY |
$56.00
Est. +23%
|
$45.61 | $62.58 |
Target Met
|
$37.58
-17.6%
|
| Sep 18, 2024 |
Zymeworks BC Inc
ZYME
|
SELL |
$10.00
Est. +19%
|
$12.30 | $9.04 (Low) |
Target Met
|
$26.31
-113.9%
|
| May 06, 2024 |
Blueprint Medicines Corp
BPMC
|
SELL |
$97.00
Est. +10%
|
$107.19 | $73.08 (Low) |
Target Met
|
$129.46
-20.8%
|
| Jul 12, 2023 |
Astrazeneca plc - ADR
AZN
|
BUY |
$79.00
Est. +22%
|
$64.86 | $79.79 |
Bullseye Hit (±1%)
|
$195.15
+200.9%
|
| Mar 27, 2023 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$976.00
Est. +19%
|
$820.00 | - | - |
$654.27
-20.2%
|
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Jun 03, 2026
Signal & Target
BUY
$165.00
Start Price
$91.35
Best Price (1Y)
$123.80
Current Price
$123.73
Return
+35.4%
Zymeworks BC Inc
ZYME
Jun 03, 2026
Signal & Target
BUY
$46.00
Start Price
$24.11
Best Price (1Y)
$27.14
Current Price
$26.31
Return
+9.1%
Celcuity Inc
CELC
Jun 02, 2026
Signal & Target
BUY
$155.00
Start Price
$93.37
Best Price (1Y)
$108.32
Current Price
$107.95
Return
+15.6%
Immunome Inc
IMNM
May 15, 2026
Signal & Target
BUY
$33.00
Start Price
$22.02
Best Price (1Y)
$23.67
Current Price
$23.61
Return
+7.2%
Regeneron Pharmaceuticals, Inc.
REGN
Dec 17, 2025
Signal & Target
BUY
$873.00
Start Price
$746.36
Best Price (1Y)
$821.11
Current Price
$654.27
Return
-12.3%
Zymeworks BC Inc
ZYME
Nov 17, 2025
Signal & Target
BUY
$37.00
Start Price
$23.90
Best Price (1Y)
$29.75
Current Price
$26.31
Return
+10.1%
Zentalis Pharmaceuticals Inc
ZNTL
Nov 11, 2025
Signal & Target
BUY
$2.00
Start Price
$1.32
Best Price (1Y)
$6.95
Current Price
$4.46
Return
+237.9%
Compass Therapeutics Inc
CMPX
Apr 02, 2025
Signal & Target
BUY
$6.00
Start Price
$1.69
Best Price (1Y)
$6.77
Current Price
$2.27
Return
+34.3%
Lilly(Eli) & Co
LLY
Jan 17, 2025
Signal & Target
BUY
$950.00
Start Price
$740.15
Best Price (1Y)
$1,133.95
Current Price
$1,210.50
Return
+63.5%
Zymeworks BC Inc
ZYME
Nov 21, 2024
Signal & Target
BUY
$26.00
Start Price
$13.68
Best Price (1Y)
$26.19
Current Price
$26.31
Return
+92.3%
Ideaya Biosciences Inc
IDYA
Nov 05, 2024
Signal & Target
SELL
$27.00
Start Price
$29.58
Best Price (1Y)
$13.45
Current Price
$37.65
Return
-27.3%
Regeneron Pharmaceuticals, Inc.
REGN
Nov 01, 2024
Signal & Target
BUY
$880.00
Start Price
$843.60
Best Price (1Y)
$862.00
Current Price
$654.27
Return
-22.4%
Gilead Sciences, Inc.
GILD
Oct 21, 2024
Signal & Target
BUY
$96.00
Start Price
$86.72
Best Price (1Y)
$124.61
Current Price
$131.27
Return
+51.4%
Lilly(Eli) & Co
LLY
Oct 14, 2024
Signal & Target
BUY
$990.00
Start Price
$932.06
Best Price (1Y)
$937.00
Current Price
$1,210.50
Return
+29.9%
Agios Pharmaceuticals Inc
AGIO
Sep 27, 2024
Signal & Target
BUY
$56.00
Start Price
$45.61
Best Price (1Y)
$62.58
Current Price
$37.58
Return
-17.6%
Zymeworks BC Inc
ZYME
Sep 18, 2024
Signal & Target
SELL
$10.00
Start Price
$12.30
Best Price (1Y)
$9.04
Current Price
$26.31
Return
-113.9%
Blueprint Medicines Corp
BPMC
May 06, 2024
Signal & Target
SELL
$97.00
Start Price
$107.19
Best Price (1Y)
$73.08
Current Price
$129.46
Return
-20.8%
Astrazeneca plc - ADR
AZN
Jul 12, 2023
Signal & Target
BUY
$79.00
Start Price
$64.86
Best Price (1Y)
$79.79
Current Price
$195.15
Return
+200.9%
Regeneron Pharmaceuticals, Inc.
REGN
Mar 27, 2023
Signal & Target
BUY
$976.00
Start Price
$820.00
Best Price (1Y)
-
Current Price
$654.27
Return
-20.2%